Iervasi, E.; Coronel Vargas, G.; Bachetti, T.; Tkachenko, K.; Spallarossa, A.; Brullo, C.; Rosano, C.; Carta, S.; Barboro, P.; Profumo, A.;
et al. A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells. Int. J. Mol. Sci. 2024, 25, 6760.
https://doi.org/10.3390/ijms25126760
AMA Style
Iervasi E, Coronel Vargas G, Bachetti T, Tkachenko K, Spallarossa A, Brullo C, Rosano C, Carta S, Barboro P, Profumo A,
et al. A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells. International Journal of Molecular Sciences. 2024; 25(12):6760.
https://doi.org/10.3390/ijms25126760
Chicago/Turabian Style
Iervasi, Erika, Gabriela Coronel Vargas, Tiziana Bachetti, Kateryna Tkachenko, Andrea Spallarossa, Chiara Brullo, Camillo Rosano, Sonia Carta, Paola Barboro, Aldo Profumo,
and et al. 2024. "A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells" International Journal of Molecular Sciences 25, no. 12: 6760.
https://doi.org/10.3390/ijms25126760
APA Style
Iervasi, E., Coronel Vargas, G., Bachetti, T., Tkachenko, K., Spallarossa, A., Brullo, C., Rosano, C., Carta, S., Barboro, P., Profumo, A., & Ponassi, M.
(2024). A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells. International Journal of Molecular Sciences, 25(12), 6760.
https://doi.org/10.3390/ijms25126760
